CO [Chinard Bloodrp] SC 13D/A: Page of Pages CUSIP No.G21107100HEDULE 13D/A 1 NAME

[Page of Pages CUSIP No.G21107100HEDULE 13D/A 1 NAME OF REPORTING PERSON Golden Meditech Stem Cells (BVI)mpany Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO 5 6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands]

By | 2016-02-04T17:48:57+00:00 June 23rd, 2011|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2011 4Q11 Revenue Up 33.7% YOY to RMB94.7 Million 4Q11 Net Income Attributable to Shareholders Up 62.8% YOY to RMB26.3 Million FY2011 Revenue Up 29.8% YOY to RMB339.5 Million FY2011 Total Subscriber Sign-ups Reached 185,830 Conference Call to be held Monday, June 13, 2011]

By | 2016-02-29T15:28:27+00:00 June 10th, 2011|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Reports Financial Results for

[China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2011 4Q11 Revenue Up 33.7% YOY to RMB94.7 Million 4Q11 Net Income Attributable to Shareholders Up 62.8% YOY to RMB26.3 Million FY2011 Revenue Up 29.8% YOY to RMB339.5 Million FY2011 Total Subscriber Sign-ups Reached 185,830 Conference Call to be held Monday, June 13, 2011]

By | 2016-02-29T15:30:29+00:00 June 10th, 2011|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: (Original Filing)

[Chinard Bloodrporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2011 4Q11 Revenue Up 33.7% YOY to RMB94.7 Million 4Q11 Netome Attributable to Shareholders Up 62.8% YOY to RMB26.3 Million FY2011 Revenue Up 29.8% YOY to RMB339.5 Million FY2011 Total Subscriber Sign-ups Reached 185,830]

By | 2016-02-04T17:50:01+00:00 June 10th, 2011|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: Chinard Bloodrporation Reports Financial Results for the Fourth

[Chinard Bloodrporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2011 4Q11 Revenue Up 33.7% YOY to RMB94.7 Million 4Q11 Netome Attributable to Shareholders Up 62.8% YOY to RMB26.3 Million FY2011 Revenue Up 29.8% YOY to RMB339.5 Million FY2011 Total Subscriber Sign-ups Reached 185,830]

By | 2016-02-04T17:50:30+00:00 June 10th, 2011|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Announces Results of 2010 Annual General Meeting HONG KONG, China, February 22, 2011 - China Cord Blood Corporation (NYSE: CO) (“CCBC” or "the Company"), the first and largest cord blood banking operator in China, today announced the results of its 2010 Annual General Meeting, which was held on February 18, 2011, in Hong Kong. At the] [China Cord Blood Corporation Forms Zhejiang Subsidiary HONG KONG, China, February 22, 2011 - China Cord Blood Corporation Under China’s “One License per Region” policy, only one cord blood bank license is granted per province or municipality. The Zhejiang cord blood banking license would be the seventh license granted in China and represents the first license issued since 2008. Operating]

By | 2016-02-29T15:31:25+00:00 March 9th, 2011|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Announces Results of 2010

[China Cord Blood Corporation Announces Results of 2010 Annual General Meeting HONG KONG, China, February 22, 2011 - China Cord Blood Corporation (NYSE: CO) (“CCBC” or "the Company"), the first and largest cord blood banking operator in China, today announced the results of its 2010 Annual General Meeting, which was held on February 18, 2011, in Hong Kong. At the] [China Cord Blood Corporation Forms Zhejiang Subsidiary HONG KONG, China, February 22, 2011 - China Cord Blood Corporation Under China’s “One License per Region” policy, only one cord blood bank license is granted per province or municipality. The Zhejiang cord blood banking license would be the seventh license granted in China and represents the first license issued since 2008. Operating]

By | 2016-02-29T15:34:22+00:00 March 9th, 2011|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: Chinard Bloodrporation Announces Results of 2010 Annual General

[Chinard Bloodrporation Announces Results of 2010 Annual General Meeting HONG KONG, China, February 22, 2011 - Chinard Bloodrporation (NYSE:) (CCBC or "thempany"), the first and largestrd blood banking operator in China, today announced the results of its 2010 Annual General Meeting, which was held on February 18, 2011, in Hong Kong.] [Chinard Bloodrporation Forms Zhejiang Subsidiary HONG KONG, China, February 22, 2011 - Chinard Bloodrporation Under Chinas One License per Region policy, only onerd blood bank license is granted per province or municipality.The Zhejiangrd blood banking license would be the seventh license granted in China and represents the first license issued since 2008.Operating the Zhejiang subsidiary]

By | 2016-02-04T17:52:10+00:00 March 9th, 2011|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: (Original Filing)

[Chinard Bloodrporation Announces Results of 2010 Annual General Meeting HONG KONG, China, February 22, 2011 - Chinard Bloodrporation (NYSE:) (CCBC or "thempany"), the first and largestrd blood banking operator in China, today announced the results of its 2010 Annual General Meeting, which was held on February 18, 2011, in Hong Kong.] [Chinard Bloodrporation Forms Zhejiang Subsidiary HONG KONG, China, February 22, 2011 - Chinard Bloodrporation Under Chinas One License per Region policy, only onerd blood bank license is granted per province or municipality.The Zhejiangrd blood banking license would be the seventh license granted in China and represents the first license issued since 2008.Operating the Zhejiang subsidiary]

By | 2016-02-04T17:51:41+00:00 March 9th, 2011|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Reports Third Quarter and First Nine Months of Fiscal 2011 Financial Results 31.3% Increase in 3Q11 Revenue 29.4% Increase in 3Q11 Net Income Attributable to Shareholders Conference Call to be Held at 8 pm ET February 28, 2010 HONG KONG, China, February 28, 2011 -- China Cord Blood Corporation (NYSE: CO) (“CCBC” or “the Company”), China’s]

By | 2016-02-29T15:37:03+00:00 February 28th, 2011|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar